Literature DB >> 8104306

Is Cremophor EL, solvent for paclitaxel, cytotoxic?

M L Fjällskog, L Frii, J Bergh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104306     DOI: 10.1016/0140-6736(93)92735-c

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Role of formulation vehicles in taxane pharmacology.

Authors:  L van Zuylen; J Verweij; A Sparreboom
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

2.  Vitamin K prophylaxis in the newborn--again.

Authors:  J M Rennie; A W Kelsall
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

3.  Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids.

Authors:  Junping Wang; Dimitry Mongayt; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2005-01       Impact factor: 5.121

4.  Two-Pronged Anti-Tumor Therapy by a New Polymer-Paclitaxel Conjugate Micelle with an Anti-Multidrug Resistance Effect.

Authors:  Juan Du; Lanlan Zong; Mengmeng Li; Keke Yu; Yonghui Qiao; Qi Yuan; Xiaohui Pu
Journal:  Int J Nanomedicine       Date:  2022-03-22

Review 5.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.

Authors:  Li Mu; Si-Shen Feng
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

7.  Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery.

Authors:  Yonglu Wang; Xueming Li; Liyao Wang; Yuanlong Xu; Xiaodan Cheng; Ping Wei
Journal:  Int J Nanomedicine       Date:  2011-07-13

8.  Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity.

Authors:  Po-Chang Chiang; Stephen Gould; Michelle Nannini; Ann Qin; Yuzhong Deng; Alfonso Arrazate; Kimberly R Kam; Yingqing Ran; Harvey Wong
Journal:  Nanoscale Res Lett       Date:  2014-04-01       Impact factor: 4.703

9.  Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.

Authors:  Lulu Cai; Xianhuo Wang; Wenwen Wang; Neng Qiu; Jiaolin Wen; Xingmei Duan; Xia Li; Xiang Chen; Li Yang; Zhiyong Qian; Yuquan Wei; Lijuan Chen
Journal:  Int J Nanomedicine       Date:  2012-08-14

10.  Optimization of Paclitaxel Containing pH-Sensitive Liposomes By 3 Factor, 3 Level Box-Behnken Design.

Authors:  Smita Rane; Bala Prabhakar
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.